Beam Therapeutics (BEAM) Other Non-Current Liabilities (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Other Non-Current Liabilities data on file, last reported at $305000.0 in Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $305000.0, down 95.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $305000.0 (down 95.19% YoY), and the FY2025 annual result was $173000.0, down 96.8% from the prior year.
• Other Non-Current Liabilities climbed to $305000.0 in Q1 2026 per BEAM's latest filing, from $173000.0 in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $30.9 million in Q1 2022 and troughed at $173000.0 in Q1 2023.
• A 5-year average of $4.0 million and a median of $1.1 million in 2024 frame the typical range for Other Non-Current Liabilities.
• On a YoY basis, Other Non-Current Liabilities climbed as much as 3371.48% in 2023 and fell as far as 99.44% in 2023.
• A 5-year view of Other Non-Current Liabilities shows it stood at $1.4 million in 2022, then soared by 97.61% to $2.7 million in 2023, then surged by 98.46% to $5.4 million in 2024, then slumped by 96.8% to $173000.0 in 2025, then soared by 76.3% to $305000.0 in 2026.
• Business Quant data shows BEAM's Other Non-Current Liabilities at $305000.0 in Q1 2026, $173000.0 in Q4 2025, and $266000.0 in Q3 2025.